Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Urinary Bladder Neoplasms × zimberelimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 2 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Cholangiocarcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Urothelial Bladder Carcinoma 1 Urinary Bladder Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thymoma 1 Stomach Neoplasms 1 Sarcoma 1 Rectal Neoplasms 1 Pharyngeal Neoplasms 1 Oropharyngeal Neoplasms 1 Oligometastatic Prostate Cancer 1 Mouth Neoplasms 1 Melanoma 1 Lung Diseases 1 Locally Advanced Pancreatic Cancer 1 Locally Advanced Cervical Cancer 1 Liver Neoplasms 1 Liposarcoma 1 Laryngeal Neoplasms 1 Kidney Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Gemcitabine 85 Cisplatin 65 Cystectomy 37 pembrolizumab 34 Docetaxel 25 Nivolumab 24 durvalumab 21 Paclitaxel 19 Radiotherapy 17 Magnetic Resonance Spectroscopy 17 Mitomycin 16 Carboplatin 16 atezolizumab 15 Doxorubicin 14 Cystoscopy 13 BCG Vaccine 13 Surveys and Questionnaires 12 Standard of Care 12 avelumab 11 Sunitinib 10 tremelimumab 9 Ipilimumab 9 Filgrastim 9 Blood Specimen Collection 9 Transurethral Resection of Bladder 8 Specimen Handling 8 Neoadjuvant Therapy 8 Methotrexate 8 Methods 8 Early Intervention, Educational 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06528483 2024-07-30

preSAVE

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Not yet recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡